Les troubles psychiatriques en soins palliatifs et en fin de vie

Reich, 2014, Troubles anxieux, dépression, confusion mentale, 336 Miovic, 2007, Psychiatric disorders in advanced cancer, Cancer, 110, 1665, 10.1002/cncr.22980 Delgado-Guay, 2009, Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting, Support Care Cancer, 17, 573, 10.1007/s00520-008-0529-7 Mitchell, 2011, Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative care settings: a meta-analysis of 94 interview-based studies, Lancet Oncol, 12, 160, 10.1016/S1470-2045(11)70002-X Dauchy, 2002, Prise en charge de l’anxiété en soins palliatifs : privilégier un traitement étiologique, Med Palliat, 1, 19 Roth, 2007, Anxiety and its management in advanced cancer, Curr Opin Support Palliat Care, 1, 50, 10.1097/SPC.0b013e32813aeb23 Grabsch, 2006, Psychological morbidity and quality of life in women with advanced breast cancer: a cross-sectional survey, Palliat Support Care, 4, 47, 10.1017/S1478951506060068 Mystakidou, 2011, The mediation effect of anxiety between post-traumatic stress symptoms and preparatory grief in advanced cancer patients, J Pain Symptom Manage, 41, 511, 10.1016/j.jpainsymman.2010.06.014 Anderson, 2005, Le syndrome sérotoninergique : un risque latent en soins palliatifs, J Eur Soins Palliat (JESP), 12, 97 Farriols, 2012, Changes in the prescription of psychotropic drugs in the palliative care of advanced cancer patients over a seven-year period, J Pain Symptom Manage, 43, 945, 10.1016/j.jpainsymman.2011.05.010 Giroud, 2013, Utilisation du midazolam chez les patients hospitalisés : analyse des pratiques, Bull Cancer, 100, 811, 10.1684/bdc.2013.1795 SFAP, 2014 Both, 2014, Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin, Expert Rev Neurother, 14, 29, 10.1586/14737175.2014.853617 Candy, 2012, Drug therapy for symptoms associated with anxiety in adult palliative care patients, Cochrane Database Syst Rev, 10, CD004596 Payne, 2000, Anxiety in palliative care, 63 Julião, 2013, Efficacy of dignity therapy for depression and anxiety in terminally ill patients: early results of a randomized controlled trial, Palliat Support Care, 19, 1 Chochinov, 2011, Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial, Lancet Oncol, 12, 753, 10.1016/S1470-2045(11)70153-X Hosie, 2013, Delirium prevalence, incidence, and implications for screening in specialist palliative care inpatient settings: a systematic review, Palliat Med, 27, 486, 10.1177/0269216312457214 Irwin, 2013, Clarifying delirium management: practical, evidence-based, expert recommendations for clinical practice, J Palliat Med, 16, 423, 10.1089/jpm.2012.0319 Bush, 2014, End-of-life delirium: issues regarding recognition, optimal management and the role of sedation in the dying phase, J Pain Symptom Manage, 48, 215, 10.1016/j.jpainsymman.2014.05.009 Leonard, 2008, Delirium issues in palliative care settings, J Psychosom Res, 65, 289, 10.1016/j.jpsychores.2008.05.018 Reich, 2011, Quelles prises en charge de la confusion mentale en soins palliatifs ?, Med Palliat, 10, 4 LeGrand, 2012, Delirium in palliative medicine: a review, J Pain Symptom Manage, 44, 583, 10.1016/j.jpainsymman.2011.10.013 Leonard, 2014, Delirium diagnostic and classification challenges in palliative care: subsyndromal delirium, comorbid delirium-dementia, and psychomotor subtypes, J Pain Symptom Manage, 48, 199, 10.1016/j.jpainsymman.2014.03.012 Spiller, 2006, Hypoactive delirium: assessing the extent of the problem for inpatient specialist palliative care, Palliat Med, 20, 17, 10.1191/0269216306pm1097oa Ross, 1991, Delirium: phenomenologic and etiologic subtypes, Int Psychogeriatr, 3, 135, 10.1017/S1041610291000613 Meagher, 2000, Relationship between symptoms and motoric subtype of delirium, J Neuropsychiatry Clin Neurosci, 12, 51, 10.1176/jnp.12.1.51 Breitbart, 2008, Agitation and delirium at the end of life: “We couldn’t manage him”, JAMA, 300, 2898, 10.1001/jama.2008.885 Meagher, 2011, A longitudinal study of motor subtypes in delirium: relationship with other phenomenology, etiology, medication exposure and prognosis, J Psychosom Res, 71, 395, 10.1016/j.jpsychores.2011.06.001 Boettger, 2011, Phenomenology of the subtypes of delirium: phenomenological differences between hyperactive and hypoactive delirium, Palliat Support Care, 9, 129, 10.1017/S1478951510000672 Stagno, 2004, The delirium subtypes: a review of prevalence, phenomenology, pathophysiology, and treatment response, Palliat Support Care, 2, 171, 10.1017/S1478951504040234 Folstein, 1975, Mini Mental State: a practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, 12, 189, 10.1016/0022-3956(75)90026-6 Huntzinger, 1992, Clock drawing in the screening assessment of cognitive impairment in an ambulatory care setting: a preliminary report, Gen Hosp Psychiatry, 14, 142, 10.1016/0163-8343(92)90040-H Gaudreau, 2005, Fast, systematic, and continuous delirium assessment in hospitalized patients: the nursing delirium screening scale, J Pain Symptom Manage, 29, 368, 10.1016/j.jpainsymman.2004.07.009 AFSOS, 2011, Référentiels inter régionaux en Soins Oncologiques de Support: Confusion mentale en cancérologie, Oncologie, 13, 357, 10.1007/s10269-011-2037-5 Inouye, 1990, Clarifying confusion: the confusion assessment method. A new method for detection of delirium, Ann Intern Med, 113, 941, 10.7326/0003-4819-113-12-941 Laplante, 2005, Confusion assessment method. Validation d’une version française, Perspect Infirm, 3, 12 Leonard, 2014, Practical assessment of delirium in palliative care, J Pain Symptom Manage, 48, 176, 10.1016/j.jpainsymman.2013.10.024 Reich, 2003, Prise en charge de la confusion mentale (« delirium ») en soins palliatifs : l’exemple du cancer, Med Palliat, 2, 55 Lawlor, 2002, Delirium in patients with advanced cancer, Hematol Oncol Clin North Am, 16, 701, 10.1016/S0889-8588(02)00021-7 Bush, 2014, Clinical practice guidelines for delirium management: potential application in palliative care, J Pain Symptom Manage, 48, 249, 10.1016/j.jpainsymman.2013.09.023 Han, 2004, A double-blind trial of risperidone and haloperidol for the treatment of delirium, Psychosomatics, 45, 297, 10.1016/S0033-3182(04)70170-X Parellada, 2004, Risperidone in the treatment of patients with delirium, J Clin Psychiatry, 65, 348, 10.4088/JCP.v65n0310 Passik, 1999, Complicated delirium in a cancer patient successfully treated with olanzapine, J Pain Symptom Manage, 17, 219, 10.1016/S0885-3924(98)00128-6 Breitbart, 2002, An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients, Psychosomatics, 43, 175, 10.1176/appi.psy.43.3.175 Maneeton, 2013, Quetiapine versus haloperidol in the treatment of delirium: a double-blind, randomized, controlled trial, Drug Des Devel Ther, 7, 657, 10.2147/DDDT.S45575 Wang, 2013, Atypical antipsychotics in the treatment of delirium, Psychiatry Clin Neurosci, 67, 323, 10.1111/pcn.12066 Boettger, 2005, Atypical antipsychotics in the management of delirium: a review of the empirical literature, Palliat Support Care, 3, 227, 10.1017/S1478951505050352 Piollet, 2013, La confusion mentale en oncologie, Psychooncology, 7, 204 Laird, 2005, Évaluation et traitement de la dépression en soins palliatifs, J Eur Soins Palliat (JESP), 12, 101 Slovacek, 2010, Quality of life and depression among metastatic breast cancer patients, Med Oncol, 27, 958, 10.1007/s12032-009-9316-7 Tiernan, 2002, Relations between desire for early death, depressive symptoms and antidepressant prescribing in terminally ill patients with cancer, J R Soc Med, 95, 386, 10.1258/jrsm.95.8.386 Breitbart, 2000, Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer, JAMA, 284, 2907, 10.1001/jama.284.22.2907 Onitilo, 2006, Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site, Gen Hosp Psychiatry, 28, 396, 10.1016/j.genhosppsych.2006.05.006 Pirl, 2012, Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care, J Clin Oncol, 30, 1310, 10.1200/JCO.2011.38.3166 Sela, 2007, Screening for depression in palliative cancer patients attending a pain and symptom control clinic, Palliat Support Care, 5, 207, 10.1017/S1478951507000375 Hotopf, 2002, Depression in advanced disease: a systematic review part 1. Prevalence and case finding, Palliat Med, 16, 81, 10.1191/02169216302pm507oa Irwin, 2008, Psychiatric issues in palliative care: recognition of depression in patients enrolled in hospice care, J Palliat Med, 11, 158, 10.1089/jpm.2007.0140 Fisher, 2014, Prevalence and risk factors of depressive symptoms in a Canadian palliative home care population: a cross-sectional study, BMC Palliat Care, 13, 10, 10.1186/1472-684X-13-10 Wasteson, 2009, Depression assessment and classification in palliative cancer patients: a systematic literature review, Palliat Med, 23, 739, 10.1177/0269216309106978 Lavigne, 2014, Dépression, anxiété et confusion en soins palliatifs, Med Palliat, 13, 219 Pessin, 2005, Clinical assessment of depression in terminally ill cancer patients: a practical guide, Palliat Support Care, 3, 319, 10.1017/S1478951505050480 Brenne, 2013, Depressed patients with incurable cancer: which depressive symptoms do they experience?, Palliat Support Care, 11, 491, 10.1017/S1478951512000909 Phuc-Hung, 2001, Comment diagnostiquer et traiter la dépression en soins palliatifs ?, InfoKara, 64, 10 Rayner, 2011, The development of evidence-based European guidelines on the management of depression in palliative cancer care, Eur J Cancer, 47, 702, 10.1016/j.ejca.2010.11.027 Dauchy, 2013, Repérage et traitement de la dépression en cancérologie, Psychooncology, 7, 217 Rhondali, 2011, Validation linguistique et métrique de la version française de la Brief Edinburgh Depression Scale (BEDS), Bull Cancer, 98, 199, 10.1684/bdc.2011.1310 Chochinov, 1997, Are you depressed? Screening for depression in the terminally ill, Am J Psychiatry, 154, 674, 10.1176/ajp.154.5.674 Rodin, 2007, The treatment of depression in cancer patients: a systematic review, Support Care Cancer, 15, 123, 10.1007/s00520-006-0145-3 Lloyd-Williams, 1999, A survey of antidepressant prescribing in the terminally ill, Palliat Med, 13, 243, 10.1191/026921699676753309 Reich, 2010, Les antidépresseurs en oncologie : spécificités et particularités, Psychooncology, 4, 51 Grothe, 2004, Treatment of pain syndromes with venlafaxine, Pharmacotherapy, 24, 621, 10.1592/phco.24.6.621.34748 Matsuoka, 2012, Pilot study of duloxetine for cancer patients with neuropathic pain non-responsive to pregabalin, Anticancer Res, 32, 1805 Hardy, 2009, Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults, Am J Geriatr Pharmacother, 7, 34, 10.1016/j.amjopharm.2009.02.006 Sood, 2006, Use of methylphenidate in patients with cancer, Am J Hosp Palliat Care, 23, 35, 10.1177/104990910602300106 Villard, 2007, Essai clinique au centre hospitalier universitaire de Grenoble de l’utilisation du méthylphénidate en soins palliatifs, Med Palliat, 6, 261 Minton, 2011, Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis, J Pain Symptom Manage, 41, 761, 10.1016/j.jpainsymman.2010.06.020 Prommer, 2012, Methylphenidate: established and expanding roles in symptom management, Am J Hosp Palliat Care, 29, 483, 10.1177/1049909111427029 Lemaire, 2014, Kétamine et dépression : vers de nouvelles perspectives thérapeutiques en soins de support?, Psychooncology, 8, 59 Brittner, 2014, La kétamine dans le traitement du trouble dépressif aigu sévère, Presse Med, 43, 492, 10.1016/j.lpm.2013.11.013 Lam, 2007, Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants, Ann Pharmacother, 41, 1005, 10.1345/aph.1H526 Kissane, 2007, Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial, Psychooncology, 16, 277, 10.1002/pon.1185 Moorey, 2009, A cluster randomized controlled trial of cognitive behaviour therapy for common mental disorders in patients with advanced cancer, Psychol Med, 39, 713, 10.1017/S0033291708004169 Miller, 2005, Supportive-affective group experience for persons with life-threatening illness: reducing spiritual, psychological, and death-related distress in dying patients, J Palliat Med, 8, 333, 10.1089/jpm.2005.8.333 Lloyd-Williams, 2013, A pilot randomised controlled trial to reduce suffering and emotional distress in patients with advanced cancer, J Affect Disord, 148, 141, 10.1016/j.jad.2012.11.013 Rasmussen, 2011, Electroconvulsive therapy in palliative care, Am J Hosp Palliat Care, 28, 375, 10.1177/1049909110390203 Rosenstein, 2011, Depression and end-of-life care for patients with cancer, Dialogues Clin Neurosci, 13, 101, 10.31887/DCNS.2011.13.1/drosenstein Akechi, 2004, Suicidality in terminally ill Japanese patients with cancer, Cancer, 100, 183, 10.1002/cncr.11890 Hem, 2004, Suicide risk in cancer patients from 1960 to 1999, J Clin Oncol, 22, 4209, 10.1200/JCO.2004.02.052 Mystakidou, 2007, Depression, hopelessness, and sleep in cancer patients’ desire for death, Int J Psychiatry Med, 37, 201, 10.2190/0509-7332-388N-566W